2[1]Igarashi R,Takenaga M,Takeuchi J,et al.Marked hypotensive and blood flow-increasing effects of a new lipo-PGE1(lipo-AS013)due to vascular wall targeting[J].J Controlled Release,2001,71(2):157-164.
3[2]Foldvari M,Oguejiofor CJN,Wilson TW,et al.Transcutaneous delivery of prostaglandin E1:in vitro and laser doppler flowmetry study[J].J Pharm Sci,1998,87(6):721-725.
4[5]Godschalk MF,Chen J,Katz PG,et al.Treatment of erectile failure with prostaglandin E1:A double-blind,placebo-controlled,dose-response study[J].J Urol,1994,151(6):1530-1532.
5[6]Uekama K,Fujise A,Hirayama F,et al.Improvement of dissolution characteristics and chemical stability of prostaglandin E1 by γ-cyclodextrin complexation[J].Chem Pharm Bull,1984,32(1):275-279.
6[7]Yamamoto M,Hirayama F,Uekama K.Improvement of stability and dissolution of prostaglandin E1 by maltosyl-β-cyclodextrin in lyophilized formulation[J].Chem Pharm Bull,1992,40(3):747-751.
7[8]Adachi H,Irie T,Hirayama F,et al.Stabilization of prostaglandin E1 in fatty alcohol propylene glycol ointment by acidic cyclodextrin derivative,O-carboxymethyl-O-ethyl-β-cyclodextrin[J].Chem Pharm Bull,1992,40(6):1586-1591.
8[9]Gatti R,Gotti R,Cavrini V,et al.Stability study of prostaglandin E1(PGE1) in physiological solutions by liquid chromatography(HPLC)[J].Int J Pharm,1995,115(1):113-117.
9[10]Dollo G,Corre PL,Chollet M,et al.Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives[J].J Pharm Sci,1999,88(9):889-895.
10[11]Nina SS.The thermodynamic parameters of the formation of a complex between cyclodextrins and steroid hormones[J].J Chromatogr A,1996,728(1-2):89-95.
